These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3871370)

  • 1. Proliferative response of murine B-cell leukemia (BCL1) to poly(L-lysine).
    Morecki S; Flechner Y; Slavin S
    Cell Immunol; 1985 Feb; 90(2):392-400. PubMed ID: 3871370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution.
    Muirhead MJ; Isakson PC; Krolick KA; Uhr JW; Vitetta ES
    Am J Pathol; 1981 Dec; 105(3):295-305. PubMed ID: 7032308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.
    Muirhead MJ; Holbert JM; Uhr JW; Vitetta ES
    Am J Pathol; 1981 Dec; 105(3):306-15. PubMed ID: 6976124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
    Friedman H; Kateley JR
    Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.
    Knapp MR; Severinson-Gronowicz E; Schröder J; Strober S
    J Immunol; 1979 Sep; 123(3):1000-6. PubMed ID: 381513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiology of a spontaneous murine B cell leukemia (BCL1).
    Strober S; Gronowicz ES; Knapp MR; Slavin S; Vitetta ES; Warnke RA; Kotzin B; Schröder J
    Immunol Rev; 1979; 48():169-95. PubMed ID: 121100
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
    Weiss L; Morecki S; Vitetta ES; Slavin S
    J Immunol; 1983 May; 130(5):2452-5. PubMed ID: 6339628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis, anti-proliferation, tumor-angiogenic suppression and down-regulation of Dalton's Ascitic Lymphoma (DAL) induced tumorigenesis by poly-l-lysine: A mechanistic study.
    Debnath S; Mukherjee A; Karan S; Debnath M; Chatterjee TK
    Biomed Pharmacother; 2018 Jun; 102():1064-1076. PubMed ID: 29710523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen presentation by the BCL1 murine B cell line: in vitro stimulation by LPS.
    Harris MR; Kindle CS; Abruzzini AF; Pierce CW; Cullen SE
    J Immunol; 1984 Sep; 133(3):1202-8. PubMed ID: 6611366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA; Isakson PC; Puré E; Muirhead M; Uhr JW; Vitetta ES
    J Immunol; 1981 Apr; 126(4):1603-7. PubMed ID: 6451649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
    Cerny J; Hensgen PA; Fistel SH; Demler LM
    Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).
    Slavin S; Morecki S; Weiss L
    J Immunol; 1980 Feb; 124(2):586-9. PubMed ID: 6965384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid effects on lipopolysaccharide-stimulated murine B-cell leukemia line (BCL1) cells.
    Roess DA; Ruh TS; Bellone CJ; Ruh MF
    Cancer Res; 1983 Jun; 43(6):2536-40. PubMed ID: 6601983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1).
    Morecki S; Slavin S; Weiss L; Weigensberg M; Friedman A; Kotler M
    Leuk Res; 1984; 8(5):821-32. PubMed ID: 6333565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.
    Vitetta ES; Yuan D; Krolick K; Isakson P; Knapp M; Slavin S; Strober S
    J Immunol; 1979 May; 122(5):1649-54. PubMed ID: 109513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPS-induced differentiation of a murine B cell leukemia (BCL1): changes in surface and secreted IgM.
    Lafrenz D; Koretz S; Stratte PT; Ward RB; Strober S
    J Immunol; 1982 Sep; 129(3):1329-35. PubMed ID: 6980922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid effects on lipid lateral diffusion and membrane composition in lipopolysaccharide-activated B-cell leukemia 1 cells.
    Keating KM; Barisas BG; Roess DA
    Cancer Res; 1988 Jan; 48(1):59-63. PubMed ID: 3257163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.
    Krolick KA; Isakson PC; Uhr JW; Vitetta ES
    J Immunol; 1979 Nov; 123(5):1928-35. PubMed ID: 385772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.